Nasus Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nasus Pharma and other ETFs, options, and stocks.About NSRX
Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. It offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats.
CEODan Teleman
CEODan Teleman
Employees5
Employees5
HeadquartersTel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded2019
Founded2019
Employees5
Employees5
NSRX Key Statistics
Market cap60.72M
Market cap60.72M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume4.36K
Average volume4.36K
High today$7.20
High today$7.20
Low today$6.81
Low today$6.81
Open price$7.11
Open price$7.11
Volume4.23K
Volume4.23K
52 Week high$9.99
52 Week high$9.99
52 Week low$5.90
52 Week low$5.90
Stock Snapshot
The current Nasus Pharma(NSRX) stock price is $6.81, with a market capitalization of 60.72M.
As of 2026-01-17, Nasus Pharma(NSRX) stock has fluctuated between $6.81 and $7.20. The current price stands at $6.81, placing the stock 0.0% above today's low and -5.4% off the high.
The Nasus Pharma(NSRX)'s current trading volume is 4.23K, compared to an average daily volume of 4.36K.
In the last year, Nasus Pharma(NSRX) shares hit a 52-week high of $9.99 and a 52-week low of $5.90.
In the last year, Nasus Pharma(NSRX) shares hit a 52-week high of $9.99 and a 52-week low of $5.90.
People also own
Based on the portfolios of people who own NSRX. This list is generated using Robinhood data, and it’s not a recommendation.